Cytotoxicity and DNA binding characteristics of dextran-conjugated doxorubicins

Biochimica et Biophysica Acta - General Subjects

Volumn 1380, Issue 3, 1998, Pages 329-335

  Yang, Mengsu ^a   Chan, Hing Leung ^a   Lam, Wing ^a   Fong, W F ^a  

^a CITY UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Doxorubicin conjugate; Ligand DNA interaction; Optical biosensor

Indexed keywords

DEXTRAN; DOXORUBICIN;

ARTICLE; BIOSENSOR; CARCINOMA CELL; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG DNA BINDING; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

BINDING SITES; BIOSENSING TECHNIQUES; DEXTRANS; DNA, NEOPLASM; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; KB CELLS; KINETICS; SPECTROMETRY, FLUORESCENCE; THERMODYNAMICS;

EID: 0344835874     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(97)00161-X     Document Type: Article

References (30)

1. Cummings J., Anderson L., Willmott N., Smith J.F. Eur. J. Cancer. 27:1991;532-537.
2. Jaenke R.S., Campeneer D.D., Trout A. Cancer Res. 40:1980;3530-3534.
3. Barabas K., Sizensky J.A., Faulk W.P. J. Biol. Chem. 267:1992;9437-9442.
4. Tarasiuk J., Frezard F., Garnier-Suilerot A., Gattegno L. Biochem. Biophys. Acta. 1013:1989;109-115.
5. Hurwitz E., Levy R., Maron R., Wilchek M., Arnon R., Sela M. Cancer Res. 35:1975;1175-1181.
6. Rogers K.E., Carr B.I., Tokes Z.A. Cancer Res. 43:1983;2741-2748.
7. Willingham M.C., Richert N.D., Cornwell M.M., Tsuruo T., Hamada H., Gottesman M.M., Pastan I. J. Histochem. Cytochem. 35:1986;1451-1457.
8. Akiyama S.I., Fojo A., Hanover J.A., Pastan I., Gottesman M.M. Somatic Cell Mol. Genet. 11:1985;117-126.
9. Shen D.W., Carderalli C., Hwang J., Cornwell M.M., Richert N.D., Ishii S., Pastan I., Gottesman M.M. J. Biol. Chem. 261:1986;7762-7770.
10. Mosmann T. J. Immunol. Methods. 65:1983;55-63.
11. Chou T.C., Talalay P. Adv. Enzyme Regul. 22:1984;27-55.
12. T.C. Chou, D. Rideout, J. Chou, J.R. Bertino, in: Encyclopedia of Human Biology, Vol. 2, Academic Press, San Diego, 1991, pp. 371-379.
13. Cush R., Cronin J.M., Stewart W.J., Maule C.H., Molloy J., Goddard N.J. Biosens. Bioelectron. 8:1993;347-351.
14. Buckle P.E., Davies R.J., Kinning T., Yeung D., Edwards P.R., Pollard-Knight D., Lowe C.R. Biosens. Bioelectron. 8:1993;355-363.
15. R.J. Davies, P.R. Edwards, H.J. Watts, C.R. Lowe, P.E. Buckle, D. Yeung, T. Kinning, D. Pollard-Knight, in: Techniques in Protein Chemistry V, San Diego, Academic Press, 1994, pp. 285-292.
16. Edwards P.R., Gill A., Pollard-Knight D., Hoare M., Buckle P.E., Lowe P.A., Leatherbarrow R.J. Anal. Biochem. 231:1995;210-217.
17. Watts H.J., Yeung D., Parkes H. Anal. Chem. 67:1995;4283-4287.
18. Kong Y.C., Dung W.F., Vrijmoed L.L.P., Wu R.S.S. Marine Pollut. Bull. 31:1995;317-324.
19. Dahlquist F.W. Methods Enzymol. 48:1978;270-293.
20. Chaires J.B., Dattagupta N., Crothers D.M. Biochemistry. 21:1982;3927-3932.
21. Bosch I., Croop J. Biochem. Biophys. Acta. 1288:1996;F37.
22. Endicott J.A., Ling V. Annu. Rev. Biochem. 58:1989;137-155.
23. J.W. Lowen (Ed.), Anthracycline and Anthracenechone Based Anticancer Agents, Elsevier, Amsterdam, 1988.
24. D.J. Winzor, W.H. Sawyer, Quantitative Characterisation of Ligand Binding, Wiley-Liss, New York, 1995.
25. O'Shannessy D.J., Brigham-Burke M. Anal. Biochem. 212:1993;457-468.
26. O'Shannessy D.J. Curr. Opin. Biotechnol. 5:1994;65-71.
27. Morton T.A., Myszka D.G., Chaiken I.M. Anal. Biochem. 227:1995;176-182.
28. Nieba L., Krebber A., Pluckthun A. Anal. Biochem. 234:1996;155-161.
29. Barcelo F., Barcelo I., Bavilances F., Ferragut J.A., Yanovich S., Gonzalez-Ros J.M. Biochim. Biophys. Acta. 884:1986;172-181.
30. Rizzo V., Sacchi N., Menozzi M. Biochemistry. 28:1989;274-282.